HP Cash Equivalents and Available For Sale Securities, Amortized Cost Basis, Excluding Accrued Interest decreased by 35.1% to $1.29B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 17.1%, from $1.55B to $1.29B. Over 4 years (FY 2021 to FY 2025), Cash Equivalents and Available For Sale Securities, Amortized Cost Basis, Excluding Accrued Interest shows a downward trend with a -10.5% CAGR.
other_cash_equivalents_and_available_for_sale_securities_1f2d29| Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.09B | $3.34B | $4.19B | $2.25B | $870.00M | $1.03B | $866.00M | $2.53B | $1.57B | $1.74B | $2.09B | $2.46B | $1.55B | $2.07B | $2.28B | $1.99B | $1.29B |
| QoQ Change | — | +8.0% | +25.4% | -46.3% | -61.3% | +17.8% | -15.5% | +192.4% | -37.8% | +10.5% | +20.3% | +17.6% | -36.9% | +33.5% | +10.2% | -13.1% | -35.1% |
| YoY Change | — | — | — | -27.2% | — | -69.3% | -79.3% | +12.6% | +80.9% | +69.8% | +141.8% | -2.8% | -1.3% | +19.1% | +9.1% | -19.4% | -17.1% |